AMGN-Amgen, Inc. is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. The Company manufactures and markets human therapeutic products, including Epogen (Epoetin alfa), Neupogen (Filgrastim), Aranesp (darbepoetin alfa), Neulasta (pegfilgrastim) and Kineret (anakinra). Amgen focuses its research and development efforts on human therapeutics delivered in the form of proteins, monoclonal antibodies and small molecules in the therapeutic areas of nephrology, cancer, inflammation and neurology and metabolism.